Study title:
Progressive hearing loss in hearing impaired children: immediate results of antiphlogistic-rheologic infusion therapy. Michael Streppel, Claus Wittekindt, Hasso von Wedel, Martin Walger, Hans Jakob Schondorf, Olaf Michel, Eberhard Stennert. International Journal of Pediatric Otorhinolaryngology 57 (2001) 129-136
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Otorhinolaryngologic Diseases
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PENTOXYFILLINE |
ATC code: C04AD03 |
Document link:
|
Document date:
|
Study number: M073147/5002 |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|